AI Compliance

AI Vendor Liability Without Explainability: Inside Google Ads' New Terms

Google Ads' 2026 terms label which ad content its AI generated — but not why. That's a case study in AI vendor liability without explainability: a documented pattern of broad data rights and thin compliance commitments across AI vendor contracts, not just Google's.

💡

TL;DR:
Google Ads now labels which ad content its AI generated, but not why — a pattern of attribution without explainability that shows up across AI vendor contracts generally, not just Google's.

What you need to know

The change: New Google Ads terms reinforce advertisers' continuing responsibility to review, approve, or remove automatically generated campaigns and ad assets, and document that conversational-experience inputs and authorized crawling may be used across Google Ads features.
Who is affected: Any organization running Google Ads campaigns using conversational setup tools, AI Max, or Performance Max — and more broadly, any organization negotiating AI vendor contracts of any kind.
Why it matters: A vendor can document that AI-generated output occurred without disclosing why it occurred, while the customer retains responsibility for reviewing that output.
What to do first: For Search campaigns, locate the "Added by: Google AI" designation in asset reporting; for Performance Max, locate "Automatically created" in the "Source" column of asset group reporting. Treat either as a starting inventory, not a complete audit trail.
Key date or trigger: New terms took effect July 1, 2026, replacing terms that expired June 30, 2026.

Want the full decision layer?

Paid members receive deeper analysis, early-warning signals, and scenario breakdowns on how AI and policy shifts play out in practice.

Access the PolicyEdge AI Intelligence Terminal

Medicaid work requirements move along parallel pathways through three review points on a dark policy-intelligence grid.

Medicaid Work Requirements: What the Court Ruling Changes—and What It Doesn’t

A federal court declined to block three CMS provisions governing Medicaid work requirements. The ruling leaves the implementation timeline in place for now without resolving the legal merits.

EU AI Act Article 50 shown as linked data paths separating system marking from public disclosure.

EU AI Act Article 50: What the Transparency Rules Require

EU AI Act Article 50 is now applicable, but it does not require one universal AI label. Learn how duties differ by organizational role, system, content type and exception.

June 2026 JOLTS report visual showing subtle labor-market signals without a clear hiring trend.

June 2026 JOLTS Report: Why the Data Do Not Show a Hiring Rebound

BLS reported job openings as little changed at 7.4 million and hires as unchanged at 5.3 million in June. The data did not establish a hiring rebound—and national estimates alone cannot determine whether a company’s critical roles are becoming easier to fill.

Trump generic-drug tariffs shown as cyan supply-chain paths crossing an amber threshold and branching into uncertain routes.

Trump Generic-Drug Tariffs: What Businesses Can—and Cannot—Plan For

Trump’s announced generic-drug tariffs could reshape supply chains beginning in 2028. Here is what manufacturers, healthcare purchasers and boards can assess now—and which unanswered policy questions prevent reliable forecasts.